Brain's drain
Elie Dolgin • February 17, 2020
Lymphatics in the central nervous system are attracting both controversy and drug hunters in search of therapeutic targets for a host of diseases.
Continue reading at Nature Biotechnology.
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.